English
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
alpha prostaglandin f 2/inflammation
The link is saved to the clipboard
Page 1 from 16 results
Stabilized pharmaceutical composition of a nonsteroidal anti-inflammatory agent and a prostaglandin
Only registered users can translate articles
Log In/Sign up
TECHNICAL FIELD
This invention relates generally to pharmaceutical compositions, and more particularly relates to a pharmaceutical composition containing a combination of a nonsteroidal anti-inflammatory drug (NSAID) and a prostaglandin.
BACKGROUND ART
Nonsteroidal anti-inflammatory agents such as
Stabilized pharmaceutical composition of a nonsteroidal anti-inflammatory agent and a prostaglandin
Only registered users can translate articles
Log In/Sign up
TECHNICAL FIELD
This invention relates generally to pharmaceutical compositions, and more particularly relates to a pharmaceutical composition containing a combination of a nonsteroidal anti-inflammatory drug (NSAID) and a prostaglandin.
BACKGROUND
Nonsteroidal anti-inflammatory agents such as
Anti-inflammatory pharmaceutical formulations
Only registered users can translate articles
Log In/Sign up
This invention relates to pharmaceutical formulations of anti-inflammatory drugs, particularly non-asteroidal anti-inflammatory drugs (NSAIDs).
These NSAIDs are used for the treatment of inflammatory conditions such as osteoarthritis or rheumatoid arthritis. A side effect of the oral administration
Anti-inflammatory pharmaceutical formulations
Only registered users can translate articles
Log In/Sign up
This invention relates to pharmaceutical formulations of anti-inflammatory drugs, particularly non-steroidal anti-inflammatory drugs (NSAIDs).
These NSAIDs are used for the treatment of inflammatory conditions such as osteoarthritis or rheumatoid arthritis. A side effect of the oral administration
Reducing the incidence of gastrointestinal side effects during the treatment of inflammatory conditions with antiinflammatory drugs
Only registered users can translate articles
Log In/Sign up
BACKGROUND OF THE INVENTION
a. Field of Invention
This invention relates to a method and to compositions for reducing or treating gastrointestinal side effects caused by antiinflammatory agents. More particularly, this invention relates to the finding that the adminstration of certain prostaglandin
Compound 1-[2-[4-(2-ethyl-6,8-dimethylimidazo[1,2-.alpha.]pyrazin-3-yl)phe- nyl]ethyl]-3-(p-tolylsulfonyl)urea as a prostaglandin EP4 receptor antagonist
Only registered users can translate articles
Log In/Sign up
FIELD OF THE INVENTION
The present invention describes novel compounds, or their pharmaceutically acceptable salts, pharmaceutical compositions containing them, and their medical uses. The compounds of the invention have activity as prostaglandin EP4 receptor antagonists, and are useful in the
Dihydrogen phosphate salt of a prostaglandin D2 receptor antagonist
Only registered users can translate articles
Log In/Sign up
FIELD OF THE INVENTION
Large-scale manufacturing of a pharmaceutical composition may pose many challenges to the chemist and chemical engineer. While many of these challenges relate to the handling of large quantities of reagents and control of large-scale reactions, the handling of the final
Use of non-steroidal anti-inflammatory agents in combination with prostaglandin FP receptor agonists to treat glaucoma and ocular hypertension
Only registered users can translate articles
Log In/Sign up
FIELD OF THE INVENTION
This invention is directed to the use of non-steroidal anti-inflammatory agents, and especially certain non-steroidal cyclooxygenase inhibitors in combination with prostaglandin FP receptor agonists for treating glaucoma and/or ocular hypertension in an individual.
BACKGROUND
Use of non-steroidal anti-inflammatory agents in combination with compounds that have FP prostaglandin agonist activity to treat glaucoma and ocular hypertension
Only registered users can translate articles
Log In/Sign up
FIELD OF THE INVENTION
This invention is directed to the use of non-steroidal anti-inflammatory agents, and especially certain non-steroidal cyclooxygenase inhibitors in combination with FP prostaglandin agonists for treating glaucoma and/or ocular hypertension in an individual.
BACKGROUND OF THE
Prostaglandin transporter inhibitors
Only registered users can translate articles
Log In/Sign up
BACKGROUND OF THE INVENTION
(1) Field of the Invention
The present invention generally relates to prostaglandin transport. More specifically, the invention is directed to compounds that inhibit prostaglandin transport and subsequent COX-2 induction, and methods relating thereto.
(2) Description of
Therapeutic methods using prostaglandin EP.sub.4 agonist components
Only registered users can translate articles
Log In/Sign up
FIELD OF THE INVENTION
This invention relates to treating or preventing certain diseases or conditions using therapeutically active compounds. Particularly, this invention relates to methods using prostaglandin EP.sub.4 agonist components to treat or prevent certain diseases or
Biomaterials and a method for making and using same
Only registered users can translate articles
Log In/Sign up
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to novel biomaterials including treated chitosan compositions, modified chitosan compositions, modified and treated chitosan compositions, or mixtures or combinations thereof and to methods for making and using
Bone regeneration
Only registered users can translate articles
Log In/Sign up
BACKGROUND OF THE INVENTION
1. Field of the Invention
The invention relates to methods and compositions for encouraging bone regeneration, especially after tooth loss, using non-steroidal anti-inflammatory drugs (NSAIDs).
2. Description of Related Art
Removing a tooth in dentistry can have
Tocopherol and tocotrienol aerosols
Only registered users can translate articles
Log In/Sign up
FIELD OF THE INVENTION
The field of the invention is the use of tocopherols and tocotrienols in anti-inflammatory medicaments.
BACKGROUND OF THE INVENTION
Inflammatory diseases such as rheumatoid arthritis, asthma and hepatitis are among the leading causes of death and disability in the world.
Penetrating topical medicament
Only registered users can translate articles
Log In/Sign up
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention is concerned with greatly improved topical medicaments which can penetrate the skin and transport an anti-inflammatory corticosteroid and/or an analgesic to enhance the effectiveness of such components. More particularly, it
The most complete medicinal herbs database backed by science
- Works in 55 languages
- Herbal cures backed by science
- Herbs recognition by image
- Interactive GPS map - tag herbs on location (coming soon)
- Read scientific publications related to your search
- Search medicinal herbs by their effects
- Organize your interests and stay up do date with the news research, clinical trials and patents
Type a symptom or a disease and read about herbs that might help, type a herb and see diseases and symptoms it is used against.
*All information is based on published scientific research
